Gastromedic s.r.o.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Crohn's disease2 trials
• Ulcerative colitis1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Terminated1 trial

Lead sponsor

• Celgene International II S.a.r.l.1 trial
• Celgene International II SARL1 trial
• InDex Pharmaceuticals1 trial

Closed trials

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· InDex Pharmaceuticals· Source

• Completed

  Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn's Disease

  2024-511553-22-00· Phase 3· Celgene International II SARL· Source

• Completed

  Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn's Disease

  2023-510426-33-00· Phase 3· Celgene International II S.a.r.l.· Source